Hennion & Walsh Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
BWCS
BWM
SFWA
PAM
SFA
AWM
FFA
MPWT
EWP
Hennion & Walsh Asset Management's ALT Position: Q2 2026 in Review
Hennion & Walsh Asset Management increased its Altimmune (ALT) stake by 157% in Q2 2026, buying an estimated $944K and bringing the position to 518,198 shares worth $1.58M. The position accounts for 0.05% of the portfolio, ranked #445.
Hennion & Walsh Asset Management first reported a position in ALT in Q2 2024 and has held it in 9 quarters since. 14 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Hennion & Walsh Asset Management held 518,198 shares of Altimmune worth $1.58M as of Q2 2026.
- Hennion & Walsh Asset Management bought 316,209 Altimmune shares in Q2 2026, an estimated $944K.
- Altimmune made up 0.05% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #445 holding.
- Hennion & Walsh Asset Management first reported a position in Altimmune in Q2 2024 and has held it in 9 quarters since.
- 14 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.